Characterisation and glucoregulatory actions of a novel acylated form of the (Pro3)GIP receptor antagonist in type 2 diabetes. (Q38305293)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17261080%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

title

Characterisation and glucoregulatory actions of a novel acylated form of the (Pro3)GIP receptor antagonist in type 2 diabetes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17261080%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17261080%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Nigel Irwin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17261080%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Finbarr O'Harte

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17261080%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Peter R. Flatt

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17261080%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

6

Patrick Harriott

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17261080%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

2

Kerry Hunter

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17261080%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

author name string

Brett Greer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17261080%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Brian D Green

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17261080%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

publication date

1 February 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17261080%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17261080%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

volume

388

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17261080%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17261080%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

page(s)

173-179

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17261080%20AND%20SRC:MED&resulttype=core&format=json

Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide.

24 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1515%2FBC.2007.019

Characterization of the cellular and metabolic effects of a novel enzyme-resistant antagonist of glucose-dependent insulinotropic polypeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2007.019

Glucose-dependent insulinotropic polypeptide (GIP): anti-diabetic and anti-obesity potential?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2007.019

Chemical ablation of gastric inhibitory polypeptide receptor action by daily (Pro3)GIP administration improves glucose tolerance and ameliorates insulin resistance and abnormalities of islet structure in obesity-related diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2007.019

Dose-response for glycaemic and metabolic changes 28 days after single injection of long-acting release exenatide in diabetic fatty Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2007.019

Degradation, receptor binding, insulin secreting and antihyperglycaemic actions of palmitate-derivatised native and Ala8-substituted GLP-1 analogues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2007.019

Cloning, functional expression, and chromosomal localization of the human pancreatic islet glucose-dependent insulinotropic polypeptide receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2007.019

Effects of short-term chemical ablation of the GIP receptor on insulin secretion, islet morphology and glucose homeostasis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2007.019

Bedtime administration of NN2211, a long-acting GLP-1 derivative, substantially reduces fasting and postprandial glycemia in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2007.019

Gastric inhibitory polypeptide: the neglected incretin revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2007.019

Secretion, degradation, and elimination of glucagon-like peptide 1 and gastric inhibitory polypeptide in patients with chronic renal insufficiency and healthy control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2007.019

Inhibition of gastric inhibitory polypeptide signaling prevents obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2007.019

21 January 2018

Identifiers

DOI

10.1515/BC.2007.019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17261080%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference